Log in to save to my catalogue

PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RN...

PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RN...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7b12b2ff1b34ba4925abba8cf603547

PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

About this item

Full title

PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-06, Vol.12 (1), p.9495-9495, Article 9495

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Breast cancer is the most common cancer type among women worldwide. The majority of breast cancer expresses estrogen receptor (ER) and endocrine therapy is a standard treatment of ER-positive breast cancer. However, development of the therapy resistance is still a major challenge and thus new therapeutic approaches are needed. Here we show that an...

Alternative Titles

Full title

PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d7b12b2ff1b34ba4925abba8cf603547

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7b12b2ff1b34ba4925abba8cf603547

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-13601-7

How to access this item